Cardiovascular Implants Market 2024-2033 : Industry Analysis, Size, Share, Growth And Forecast | Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc

"The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Cardiovascular Implants Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The cardiovascular implants market size has grown strongly in recent years. It will grow from $24.81 billion in 2023 to $26.8 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to aging population and cardiovascular risk, lifestyle-related cardiovascular risk factors, improvements in diagnostic technologies, growing awareness and screening programs, government initiatives for cardiovascular health..

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $34.59 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to personalized medicine approaches, focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, patient-centric cardiovascular care.. Major trends in the forecast period include advancements in drug-eluting stents, rise of next-generation heart valves, increasing integration of artificial intelligence (ai), focus on minimally invasive implantation techniques, personalized and patient-specific implants, development of leadless pacemakers..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp

Market Segmentation:
The cardiovascular implants market covered in this report is segmented -

1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Major Driver - Rising Prevalence Of Heart Disorders
The rising prevalence of heart disorders is expected to propel the growth of the cardiovascular implants market going forward. Heart disorders refer to various medical conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and valve disorders. The prevalence of heart diseases, such as coronary artery disease and heart failure, drives the demand for cardiovascular implants, including stents and pacemakers, to treat these conditions. These implants support the heart and circulation in patients with heart failure, help the heart beat in a regular rhythm, and keep track of the heart rhythm. For instance, in April 2023, according to the British Heart Foundation, a UK-based cardiovascular research charity, the overall number of deaths in Scotland from all heart and circulatory illnesses was 17,639 in 2021, up from 17,448 in 2020. In addition, the number of deaths from coronary heart disease in the UK in 2021 will be 65,579, up from 64,170 in 2020. Therefore, the rising prevalence of heart disorders is driving the growth of the cardiovascular implants market.

Competitive Landscape:
Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.